ETFs positioned on ConvaTec Group Plc

Name YTD change Weight AuM
+10.34% - 27,154 M€
+1.40% - 293 M€
+5.03% - 1,193 M€
+0.72% - 51 M€
+11.06% - 24,432 M€
+7.51% - 274 M€
+7.35%1.79% 1,882 M€
+12.67%1.7% 19 M€
+12.91%1.55% 38 M€
+7.76%1.55% 90 M€
+12.04%1.22% 361 M€
+12.78%1.21% 138 M€
+6.59%0.89% 35 M€
+14.16%0.89% 43 M€
+14.50%0.89% 3 M€
+10.11%0.65% 9 M€
+2.38%0.56% 730 M€
+10.30%0.45% 241 M€
+10.70%0.45% 121 M€
+7.23%0.44% 8 M€
+0.65%0.4% 20 M€
+4.43%0.38% 58 M€
-0.39%0.38% 12 M€
+7.49%0.38% 1,018 M€
+9.85%0.38% 700 M€
+8.98%0.36% 3,620 M€
-9.32%0.35% 336 M€
+9.06%0.35% 336 M€
+1.93%0.35% 184 M€
+9.52%0.35% 5 M€
+4.83%0.34% 820 M€
-.--%0.33% 987 M€
+9.92%0.33% 987 M€
+7.14%0.33% 39 M€
+10.22%0.24% 249 M€
+15.10%0.23% 758 M€
+8.92%0.22% 374 M€
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
  1. Stock Market
  2. Stocks
  3. CTEC Stock
  4. ETFs ConvaTec Group Plc